机构:[a]Department of General Surgery, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, China[b]Department of Surgery, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China其他部门华南肿瘤学国家重点实验室中山大学肿瘤防治中心[c]Department of Anesthesiology, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China[d]Department of Ultrasound, Sun Yat-Sen University Cancer Center, Guangzhou, China临床科室超声心电科中山大学肿瘤防治中心[e]Department of Anesthesiology, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, China
Arpin, a negative regulator of the actin-related protein-2/3 (Arp2/3) complex, is downregulated and predicts poor prognosis in breast cancer patients. However, its biological relevance in breast cancer is still unclear. This study was conducted to investigate the roles of Arpin in breast cancer growth and invasion. We overexpressed Arpin expression in MCF-7 and MDA-MB-231 breast cancer cells and examined the effects of restoration of Arpin on cell proliferation, colony formation, cell cycle distribution, invasion in vitro and tumorigenesis in vivo. The related molecular mechanism(s) was determined. It was found that ectopic expression of Arpin significantly decreased cell proliferation, colony formation, and tumorigenicity. Flow cytometric analysis showed that overexpression of Arpin significantly increased the percentage of G0/G1-phase cells and decreased the percentage of S-phase cells. Moreover, restoration of Arpin impaired the invasiveness of breast cancer cells, as determined by Transwell invasion assays. Mechanistically, overexpression of Arpin inhibited the phosphorylation of Akt in breast cancer cells. Co-expression of a constitutively active form of Akt blunted the suppression of cell proliferation and invasion by Arpin. Taken together, we provide evidence that Arpin acts as a tumor suppressor in breast cancer, which is associated with inhibition of Akt signaling. Restoration of Arpin may represent a promising therapeutic strategy against breast cancer progression. (C) 2017 Elsevier Masson SAS. All rights reserved.
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|3 区医学
小类|3 区药学4 区医学:研究与实验
最新[2023]版:
大类|2 区医学
小类|1 区药学2 区医学:研究与实验
第一作者:
第一作者机构:[a]Department of General Surgery, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, China
共同第一作者:
通讯作者:
通讯机构:[e]Department of Anesthesiology, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, China[*1]Department of Anesthesiology, The Fifth Affiliated Hospital, Sun Yat-Sen University, No 52, Meihuadong Road, Zhuhai 519000, China.
推荐引用方式(GB/T 7714):
Yi Li,Jiliang Qiu,Ting Pang,et al.Restoration of Arpin suppresses aggressive phenotype of breast cancer cells[J].BIOMEDICINE & PHARMACOTHERAPY.2017,92:116-121.doi:10.1016/j.biopha.2017.05.053.
APA:
Yi Li,Jiliang Qiu,Ting Pang,Zhixing Guo,Yonghui Su...&Xuexia Zhang.(2017).Restoration of Arpin suppresses aggressive phenotype of breast cancer cells.BIOMEDICINE & PHARMACOTHERAPY,92,
MLA:
Yi Li,et al."Restoration of Arpin suppresses aggressive phenotype of breast cancer cells".BIOMEDICINE & PHARMACOTHERAPY 92.(2017):116-121